This report shows public data only. Is this your organisation? If so, login here to view your full report.

AS Trigon Asset Management

PRI reporting framework 2020

You are in Direct - Listed Equity Incorporation » ESG incorporation in actively managed listed equities » Implementation processes » (A) Implementation: Screening

(A) Implementation: Screening

LEI 04. Types of screening applied

04.1. Indicate and describe the type of screening you apply to your internally managed active listed equities.

Type of screening

Screened by


All funds managed by Trigon do not invest in companies that are involved in the following products and services:

Products and services:


Cluster bombs, landmines
Chemical and biological weapons
Nuclear weapons
Weapons and/or munitions

Fund manager’s comments: We exclude companies in which thermal coal production comprises more than 50% of the revenue

Genetically modified organisms (GMO)

Violation of international norms

Screened by


All managed funds avoid investing in companies involved in violations of international norms and conventions (at least the UN Global Compact and OECD guidelines for multinational companies) in relation to the environment, human rights, labour practices, and business ethics.

The funds avoid investing in all companies identified as failing to comply with international norms.

04.2. Describe how you notify clients and/or beneficiaries when changes are made to your screening criteria.

By publishing our responsible investment procedures. 

LEI 05. Processes to ensure screening is based on robust analysis

05.1. Indicate which processes your organisation uses to ensure ESG screening is based on robust analysis.

05.5. Additional information. [Optional]

LEI 06. Processes to ensure fund criteria are not breached (Private)